Only one drug has been even provisionally approved--Aduhelm--and that approval is so mired in controversy that everyone is refusing to pay for it, so I doubt its company has made even a million dollars in revenue off of it.
No, Alzheimer's has been a multibillion dollar sinkhole for drug development cash with absolutely nothing to show for it.
No, they lost money on it. Clinical trials aren't cheap.
How? They aren't getting revenue until they can sell a drug that has passed clinical trials, and no clinical trials have been successful for Alzheimer's.